Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JM Finn is a leading UK-based wealth management firm that provides personalized investment services to private individuals, families, trusts, and charities. Founded in 1946, the company specializes in discretionary and advisory investment management, as well as wealth planning and corporate broking. While the firm manages portfolios that may include investments in the life sciences and healthcare sectors, it is not a biotechnology or pharmaceutical company itself. JM Finn is headquartered in London and operates several regional offices across the United Kingdom, focusing on long-term capital preservation and growth for its clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JM Finn & Co.